医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Sanchaeman Launches Ready Meals Brand ‘Bibyeoyo’ for Korean Traditional Gondeure-Bap

2019年07月24日 PM09:00
このエントリーをはてなブックマークに追加


 

INJE, GANGWON-DO, South Korea

A traditional Korean food Gondeure-bap, which is the rice cooked with Korean thistle (Gondeure), is now available worldwide.

Sanchaeman Co., Ltd., a Korean food supplier that provides fresh foods made of farm products from Gangwon-do, has launched the Bibyeoyo, a pre-cooked Gondeure with which consumers make Gondeure-bap quick and easy.

Sanchaeman’s Bibyeoyo only uses blanched Gondeure from Gangwon-do without any chemical additives and contains fermented raw bellflower essence to add a deep flavor. Consumers just can pour the contents over a bowl of rice and mix well to make a delicious meal full of nutrition. It’s also a perfect fit for vegetarians.

Korean thistle, also known as Goryeo thistle, is a type of wild edible greens that has a unique light, smooth and aromatic flavor. It contains a variety of vitamins and beta carotene. It also boasts rich fiber content and low-calories.

When eaten blanched, steamed, or seasoned, the gondeure helps bowel movements to relieve constipation and improve skin health.

“Bibyeoyo is nutritious and convenient to eat. It’s the best food for busy modern people,” said Sang-mi Park, a president of Sanchaeman.

Sanchaeman’s Bibyeoyo has four types of flavor: earthy, a little spicy, Sanchaebibim, and Gangdoenjang.

It can be purchased from Kangwonmall, Gangwon-do’s specialty foods website: http://chan24.co.kr

View source version on businesswire.com: https://www.businesswire.com/news/home/20190724005039/en/

CONTACT

Sanchaeman Co., Ltd.

Sang-mi Park

+82-33-461-1062

tkdal7877@hanmail.net

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表